SEC Form 4 · accession 0001179110-15-015015
INTERMOLECULAR INC · IMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Irwin Federman
Director
Period of report
Nov 13, 2015
Accepted (ET)
Nov 17, 2015 · 4:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311241
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 per shareF1 | Nov 13, 2015 | P | 13,259 | $2.0023 | A | 163,259 | D | |
| Common Stock, $0.001 per shareF2 | Nov 16, 2015 | P | 51,041 | $2.0039 | A | 214,300 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction was executed in multiple trades in prices ranging from $2.00 to $2.05, inclusive. The price reported in column 4 above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- F2The transaction was executed in multiple trades in prices ranging from $2.00 to $2.05, inclusive. The price reported in column 4 above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.